Stroke, Neurology and Cerebrovascular Diseases

About Conference

We are delighted to welcome you to the 18th International Conference on Stroke, Neurology and Cerebrovascular Diseases, scheduled for April 27–28, 2027, in Paris, France. Under the theme “Advancing Precision Neurology for Better Brain Health,” this global gathering will bring together leading neurologists, stroke specialists, researchers, and healthcare professionals to discuss the latest innovations, research findings, and clinical advancements in stroke care and neurological disorders.

The conference will feature keynote sessions, scientific presentations, workshops, and networking opportunities aimed at promoting collaboration and improving patient outcomes through modern neurological approaches. Join us in the vibrant city of Paris for an inspiring exchange of knowledge, innovation, and global expertise in neurology and cerebrovascular medicine.

Why To Attend

Attending the 18th International Conference on Stroke, Neurology and Cerebrovascular Diseases offers an exceptional opportunity to connect with renowned neurologists, researchers, clinicians, and healthcare professionals from around the world. Participants will gain insights into the latest advancements in stroke management, neurovascular research, precision medicine, and innovative therapeutic approaches. The conference provides a dynamic platform for knowledge sharing, networking, collaboration, and professional growth through keynote lectures, workshops, and scientific discussions. Attendees can also showcase their research, exchange ideas with global experts, and explore future collaborations while experiencing the rich culture and history of Paris, France.

Sessions & Tracks

Neurology and Neurosurgery

Neurology is a medical specialty dedicated to the diagnosis, treatment, and management of disorders affecting the nervous system, including the brain, spinal cord, nerves, and muscles. It encompasses the study of the central, peripheral, and autonomic nervous systems and addresses conditions such as epilepsy, multiple sclerosis, neuropathies, stroke, and neurodegenerative diseases.

Neurosurgery is the surgical branch of neurological care that focuses on treating disorders of the brain, spine, and peripheral nerves through advanced surgical procedures. Neurosurgeons manage a wide range of conditions, including brain tumors, spinal disorders, trigeminal neuralgia, paralysis, and chronic back or neck pain. Modern innovations in minimally invasive surgery and advanced technologies have greatly improved surgical precision, recovery time, and patient outcomes.

Stroke and Cerebrovascular Diseases

Explore recent advances in neuroimaging, artificial intelligence-assisted stroke diagnosis, and personalized therapeutic approaches for cerebrovascular disorders. Discuss multidisciplinary care pathways, early intervention strategies, and innovative rehabilitation technologies designed to improve functional recovery and patient quality of life.Highlight risk factor management, preventive healthcare initiatives, and emerging clinical research focused on reducing the global burden of stroke and cerebrovascular complications.

Neurodegenerative Disorders and Aging

Examine the latest research and therapeutic innovations in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other neurodegenerative conditions. Focus areas include early diagnosis, disease-modifying therapies, biomarker discovery, and strategies to enhance cognitive health and quality of life in aging populations.

Discussions will also address neuroprotection, genetic influences, and emerging technologies supporting long-term neurological care and patient management.

Epilepsy and Seizure Disorders

Explore advancements in epilepsy diagnosis, seizure prediction, and personalized treatment strategies. Topics include antiepileptic therapies, neurostimulation techniques, pediatric epilepsy, and surgical interventions for refractory seizure disorders.

Attention will also be given to improving patient safety, quality of life, and long-term neurological outcomes through innovative clinical and technological approaches.

Neuroimmunology and Multiple Sclerosis

Gain insights into immune-mediated neurological disorders, including multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. Key topics include immunotherapy advances, disease progression monitoring, and precision medicine approaches.

The track also highlights emerging biomarkers, rehabilitation strategies, and multidisciplinary care models aimed at improving neurological function and patient wellbeing.

Brain Tumors and Neuro-Oncology

Discover current developments in the diagnosis and treatment of primary and metastatic brain tumors. Discussions include molecular profiling, targeted therapies, immunotherapy, minimally invasive neurosurgery, and radiation advancements.

Emphasis will be placed on improving survival outcomes, reducing treatment-related complications, and enhancing supportive care for neuro-oncology patients.

Pediatric Neurology and Developmental Disorders

Focus on neurological conditions affecting infants, children, and adolescents, including developmental delays, autism spectrum disorders, cerebral palsy, and pediatric epilepsy.

Explore advances in early diagnosis, neurodevelopmental therapies, genetic research, and family-centered care approaches that support long-term developmental and neurological health.

Neurorehabilitation and Neural Recovery

Examine innovative rehabilitation methods for patients recovering from stroke, traumatic brain injury, spinal cord injury, and other neurological impairments. Topics include robotic rehabilitation, brain-computer interfaces, virtual reality therapies, and neuroplasticity-based interventions.

The track emphasizes functional recovery, patient independence, and technologies that improve long-term neurological rehabilitation outcomes.

Headache and Migraine Disorders

Explore recent advances in the understanding, diagnosis, and treatment of migraine, cluster headaches, and chronic headache disorders. Discussions include novel pharmacological therapies, neuromodulation techniques, lifestyle interventions, and personalized management strategies.
The track also highlights the impact of headache disorders on quality of life and approaches to improving long-term patient care and prevention.

Neuromuscular Disorders

Gain insights into diseases affecting muscles, peripheral nerves, and neuromuscular junctions, including muscular dystrophy, myasthenia gravis, and amyotrophic lateral sclerosis (ALS). Topics include genetic therapies, diagnostic innovations, and emerging rehabilitation strategies.
Attention will also focus on improving mobility, symptom management, and multidisciplinary approaches to patient support and care.

Sleep Disorders and Neurological Health

Examine the relationship between sleep and neurological function, covering insomnia, narcolepsy, sleep apnea, restless leg syndrome, and circadian rhythm disorders.
Discussions will include advances in sleep diagnostics, neurophysiological monitoring, behavioral therapies, and the role of sleep in cognitive and mental health.

Traumatic Brain Injury and Concussion

Discover current approaches to the diagnosis, treatment, and recovery of traumatic brain injury (TBI) and concussion-related conditions. Topics include neuroimaging, cognitive rehabilitation, sports-related injuries, and long-term neurological complications.
The track emphasizes prevention strategies, patient monitoring, and innovative therapies supporting neural recovery and brain health.

Neurogenetics and Precision Neurology

Explore the role of genetics in neurological diseases and the growing impact of precision medicine in neurology. Key areas include genomic diagnostics, inherited neurological disorders, gene-targeted therapies, and personalized treatment planning.
The track also focuses on ethical considerations, predictive biomarkers, and future directions in neurogenetic research.

Cognitive Neuroscience and Brain Function

Focus on the mechanisms underlying memory, learning, attention, language, and decision-making processes in the human brain. Discussions include neuroimaging technologies, neural network research, and cognitive dysfunction associated with neurological disorders.
Emerging discoveries in brain plasticity and cognitive enhancement strategies will also be highlighted.

Neuropharmacology and Therapeutics

Examine the development of novel neurological drugs and therapeutic approaches targeting central and peripheral nervous system disorders. Topics include drug delivery systems, neuroprotective agents, clinical trials, and pharmacological innovations for neurological diseases.
The track also addresses medication safety, treatment efficacy, and future therapeutic trends in neurology.

Spinal Cord Disorders and Spine Health

Gain insights into spinal cord injuries, degenerative spine diseases, and neurological complications affecting spinal function. Discussions include surgical advancements, regenerative medicine, spinal imaging, and rehabilitation techniques.
Special focus will be placed on improving mobility, pain management, and long-term neurological recovery outcomes.

Neuroinformatics and Digital Neurology

Explore the integration of artificial intelligence, big data, and computational technologies in neurological research and patient care. Topics include digital biomarkers, wearable monitoring devices, predictive analytics, and AI-assisted clinical decision-making.
The track highlights how digital innovation is transforming diagnosis, treatment, and neurological healthcare delivery.

Neuroethics and Mental Health in Neurology

Discuss ethical challenges in neurological research, patient autonomy, neurotechnology, and emerging brain-based interventions. Topics also include the intersection of neurological disorders and mental health, addressing depression, anxiety, and psychosocial wellbeing.
Attention will be given to patient-centered care, ethical policymaking, and improving mental health support within neurological practice.

Advanced Stroke Prevention and Risk Reduction

Explore comprehensive strategies for preventing stroke through early risk assessment, lifestyle modification, and evidence-based clinical interventions. This track focuses on hypertension management, diabetes control, atrial fibrillation monitoring, lipid regulation, and preventive neurovascular care. Discussions will highlight emerging biomarkers, predictive analytics, and public health approaches designed to identify high-risk populations before the onset of cerebrovascular events. Experts will also examine community awareness initiatives, telemedicine-based prevention programs, and advancements in personalized medicine for stroke risk reduction. 

Acute Ischemic Stroke and Emergency Care

Gain insights into the latest developments in rapid stroke diagnosis, emergency response systems, and acute ischemic stroke management. Topics include thrombolytic therapy, mechanical thrombectomy, neurocritical care, and time-sensitive treatment protocols aimed at minimizing brain injury and improving survival rates. Discussions will explore advanced neuroimaging technologies, mobile stroke units, artificial intelligence-assisted diagnostics, and optimized hospital workflows that support faster clinical decision-making. The track also addresses emergency preparedness, multidisciplinary coordination, and evidence-based practices for acute stroke intervention. 

Neurovascular Interventions and Stroke Innovations

Examine cutting-edge neurovascular procedures and technological innovations transforming stroke treatment and cerebrovascular care. This track highlights minimally invasive interventions, endovascular therapies, stenting techniques, clot retrieval devices, and image-guided neurovascular procedures used in complex stroke cases. Discussions will focus on advancements in catheter-based technologies, robotic-assisted interventions, precision imaging, and evolving treatment protocols for ischemic and hemorrhagic stroke management. Experts will also address patient selection criteria, perioperative challenges, and post-procedural neurological monitoring to optimize clinical outcomes. Attention will be given to translational research, emerging medical devices, and collaborative approaches that continue to improve safety, efficiency, and long-term recovery in neurovascular intervention practices worldwide.

Stroke Rehabilitation and Functional Recovery

Discover innovative rehabilitation strategies designed to support neurological recovery and functional independence following stroke. Topics include neuroplasticity-based therapies, robotic rehabilitation, speech and cognitive therapy, physiotherapy, occupational rehabilitation, and assistive technologies that improve patient mobility and quality of life. Discussions will explore personalized rehabilitation programs, virtual reality applications, brain-computer interfaces, and multidisciplinary approaches that accelerate functional restoration and psychological wellbeing..

Hemorrhagic Stroke and Cerebrovascular Complications

Explore current challenges and advancements in the diagnosis and management of hemorrhagic stroke and complex cerebrovascular complications. Discussions include intracerebral hemorrhage, subarachnoid hemorrhage, aneurysm management, vascular malformations, and neurocritical care approaches for severe neurological emergencies. The track highlights innovations in surgical techniques, intensive care monitoring, neuroimaging, and targeted therapeutic interventions aimed at improving survival and neurological outcomes. Experts will also examine risk factors, secondary brain injury prevention, complication management, and rehabilitation considerations following hemorrhagic stroke events. 

Market Analysis

The global market for stroke and cerebrovascular diseases is expected to witness substantial growth by 2027, driven by the increasing prevalence of neurological disorders, aging populations, unhealthy lifestyles, and rising healthcare investments worldwide. Stroke remains one of the leading causes of death and long-term disability globally, creating a growing demand for advanced diagnostic technologies, neurovascular interventions, emergency stroke care, and rehabilitation services. The expansion of healthcare infrastructure and greater awareness regarding early stroke management are further accelerating market development.

By 2027, the cerebrovascular disease market is projected to achieve significant valuation growth due to continuous advancements in imaging systems, artificial intelligence-assisted diagnostics, thrombectomy devices, minimally invasive neurovascular procedures, and precision medicine approaches. Increasing adoption of rapid-response stroke care pathways and specialized stroke centers is improving patient outcomes while driving demand for innovative treatment solutions. Ischemic stroke continues to dominate the market segment because of its high global incidence and the growing use of thrombolytic therapies and endovascular interventions.

North America is expected to maintain a leading market share owing to advanced healthcare systems, strong reimbursement frameworks, and high adoption of neurovascular technologies. Meanwhile, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period due to rising stroke incidence, expanding hospital infrastructure, improving healthcare access, and increasing government initiatives in countries such as India, China, and Japan. Europe also continues to play a significant role through investments in stroke prevention programs and rehabilitation research.

Technological innovations including robotic rehabilitation, wearable neurological monitoring devices, tele-stroke services, and digital health platforms are transforming stroke management and long-term patient recovery. In addition, pharmaceutical companies and medical device manufacturers are investing heavily in neuroprotective drugs, clot retrieval systems, and advanced rehabilitation technologies to strengthen their market presence. The growing emphasis on preventive healthcare, early diagnosis, and multidisciplinary stroke care is expected to further contribute to market expansion through 2027.